Tianjin Zhong Xin Pharmaceutical Group Corporation Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 1,826.864 million compared to CNY 1,655.960 million a year ago. Operating income was CNY 246.922 million compared to CNY 194.667 million a year ago. Net income was CNY 212.948 million compared to CNY 169.889 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.22 a year ago.